Arvinas and Pfizer announce initial Phase 1b Data from the TACTIVE-U sub-study of Vepdegestrant in combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium Read more
Zydus, ICMR initiate Phase 2 clinical trial of Desidustat in patients with Sickle Cell Disease Read more
Parexel, Partex announce alliance to leverage AI, Big Data to accelerate drug discovery and development Read more
DCTs enable greater patient engagement through remote visits, eConsent, and patient-centric technologies Read more